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Female predominance and transmission distortion in the long-QT
syndrome
Abstract
BACKGROUND: Congenital long-QT syndrome is a disorder resulting in ventricular arrhythmias and
sudden death. The most common forms of the long-QT syndrome, types 1 and 2, are caused by
mutations in the potassium-channel genes KCNQ1 and KCNH2, respectively. Although inheritance of
the long-QT syndrome is autosomal dominant, female predominance has often been observed and has
been attributed to an increased susceptibility to cardiac arrhythmias in women. We investigated the
possibility of an unbalanced transmission of the deleterious trait. METHODS: We investigated the
distribution of alleles for the long-QT syndrome in 484 nuclear families with type 1 disease and 269
nuclear families with type 2 disease, all with fully genotyped offspring. The families were recruited in
five European referral centers for the long-QT syndrome. Mutation segregation, sex ratio, and parental
transmission were analyzed after correction for single ascertainment. RESULTS: Classic mendelian
inheritance ratios were not observed in the offspring of either female carriers of the long-QT syndrome
type 1 or male and female carriers of the long-QT syndrome type 2. Among the 1534 descendants, the
proportion of genetically affected offspring was significantly greater than that expected according to
mendelian inheritance: 870 were carriers of a mutation (57%), and 664 were noncarriers (43%,
P<0.001). Among the 870 carriers, the allele for the long-QT syndrome was transmitted more often to
female offspring (476 [55%]) than to male offspring (394 [45%], P=0.005). Increased maternal
transmission of the long-QT syndrome mutations to daughters was also observed, possibly contributing
to the excess of female patients with autosomal dominant long-QT syndrome. CONCLUSIONS:
Positive selection of the mutated alleles that cause the long-QT syndrome leads to transmission
distortion, with increased proportions of mutation carriers among the offspring of affected families.
Alleles for the long-QT syndrome are more often transmitted to daughters than to sons.
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A bs tr ac t
Background
Congenital long-QT syndrome is a disorder resulting in ventricular arrhythmias and 
sudden death. The most common forms of the long-QT syndrome, types 1 and 2, 
are caused by mutations in the potassium-channel genes KCNQ1 and KCNH2, respec-
tively. Although inheritance of the long-QT syndrome is autosomal dominant, female 
predominance has often been observed and has been attributed to an increased 
susceptibility to cardiac arrhythmias in women. We investigated the possibility of 
an unbalanced transmission of the deleterious trait.
Methods
We investigated the distribution of alleles for the long-QT syndrome in 484 nuclear 
families with type 1 disease and 269 nuclear families with type 2 disease, all with 
fully genotyped offspring. The families were recruited in five European referral cen-
ters for the long-QT syndrome. Mutation segregation, sex ratio, and parental transmis-
sion were analyzed after correction for single ascertainment.
Results
Classic mendelian inheritance ratios were not observed in the offspring of either 
female carriers of the long-QT syndrome type 1 or male and female carriers of the 
long-QT syndrome type 2. Among the 1534 descendants, the proportion of geneti-
cally affected offspring was significantly greater than that expected according to 
mendelian inheritance: 870 were carriers of a mutation (57%), and 664 were non-
carriers (43%, P<0.001). Among the 870 carriers, the allele for the long-QT syndrome 
was transmitted more often to female offspring (476 [55%]) than to male offspring 
(394 [45%], P = 0.005). Increased maternal transmission of the long-QT syndrome 
mutations to daughters was also observed, possibly contributing to the excess of 
female patients with autosomal dominant long-QT syndrome.
Conclusions
Positive selection of the mutated alleles that cause the long-QT syndrome leads to 
transmission distortion, with increased proportions of mutation carriers among 
the offspring of affected families. Alleles for the long-QT syndrome are more often 
transmitted to daughters than to sons.
Copyright © 2006 Massachusetts Medical Society. All rights reserved. 
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Congenital long-qt syndrome is a rare cardiac disorder; affected persons present with prolongation of the QT inter-
val corrected for heart rate (QTc interval). These 
patients are at increased risk for syncope and sud-
den death due to life-threatening ventricular ar-
rhythmias. In the majority of cases, inheritance 
of the long-QT syndrome is autosomal dominant 
but can also be recessive, with or without associ-
ated deafness. The genetic causes of the long-QT 
syndrome have been well characterized.1 Muta-
tions in the potassium-channel genes KCNQ1 and 
KCNH2 cause the most frequent forms of the long-
QT syndrome: types 1 and 2, respectively.
Female predominance among patients with 
the long-QT syndrome has been reported,2-6 and 
results of studies of patients with the long-QT 
syndrome show a persistent excess of affected 
women.7,8 Reasons underlying the observed fe-
male predominance have not been thoroughly 
explored, and unanswered questions remain. Be-
cause the QTc interval is the main criterion for 
a diagnosis of the long-QT syndrome, women 
might be more likely to receive the diagnosis be-
cause their QTc interval is longer than that of 
men.9 It is unclear whether the observed unbal-
anced distribution between men and women in 
the population with clinically recognized long-QT 
syndrome is due to ascertainment bias or whether 
mutations causing the long-QT syndrome might 
have an increased penetrance among women.
An abnormally high rate of maternal transmis-
sion has been reported in a limited number of 
families with the long-QT syndrome.4 However, 
although most investigations have focused on cor-
relations between phenotype and genotype, on 
prognostic markers, or on both in patients and 
their family members with symptomatic long-QT 
syndrome,5,8,10 the transmission of mutations 
causing the long-QT syndrome has not been stud-
ied in a systematic manner.
Our retrospective study investigated the trans-
mission and distribution of the mutated alleles 
in a large number of families with the long-QT 
syndrome who were genotyped, after correction 
for ascertainment bias. We aimed to elucidate 
whether the autosomal dominant mutations that 
cause the long-QT syndrome types 1 and 2 follow 
classical mendelian inheritance or whether fe-
male predominance could be influenced by an un-
balanced sex ratio in the population carrying the 
deleterious allele.
Me thods
Study Population, Genotyping, 
and Phenotyping
All family members with the long-QT syndrome 
who participated in the study gave written in-
formed consent before the genetic and clinical 
investigations, in accordance with the standards 
of the Declaration of Helsinki and local ethics 
committees.
This retrospective study involving pedigrees 
of patients with clinically and molecularly diag-
nosed long-QT syndrome type 1 or type 2 is a 
collaborative project comprising five European 
referral centers. The smallest families included 
one parent with the long-QT syndrome and his 
or her fully genotyped offspring. The larger pedi-
grees were divided into nuclear families, consist-
ing of the parent with the long-QT syndrome (ei-
ther molecularly defined or an obligate carrier) 
and the offspring. All nuclear families with even 
one nongenotyped descendant were excluded, as 
were nuclear families in which two mutations 
for the long-QT syndrome were transmitted. We 
studied 240 pedigrees involving 142 distinct mu-
tations (for details, see the Supplementary Appen-
dix, available with the full text of this article at 
www.nejm. org). Our study population consisted 
of 484 nuclear families with the long-QT syn-
drome type 1 and 269 nuclear families with the 
long-QT syndrome type 2. Genotyping and phe-
notyping were performed at each center accord-
ing to standard methods. Mutations were defined 
as variations in DNA sequence that cosegregated 
with the disease phenotype, that were absent in 
300 unrelated control subjects from the same eth-
nic background as the patient, and that induced 
an amino acid change or a premature stop codon. 
Information about phenotype — consisting of the 
measured QTc interval, clinical symptoms, and 
presence or absence of a family history of sud-
den death related to the long-QT syndrome — 
was available for 885 parental and descendant 
carriers (480 carriers of type 1 and 405 carriers 
of type 2). Clinical symptoms were defined as 
syncope of unknown cause, an aborted cardiac 
arrest, or documented torsade de pointes. Phe-
notypic characteristics of the Finnish carriers of 
the KCNQ1 mutation resulting in the G589D amino 
acid substitution have been reported in detail 
elsewhere11 and were thus not included in this 
study.
Copyright © 2006 Massachusetts Medical Society. All rights reserved. 
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Analysis of Mendelian Inheritance 
and Correction of Ascertainment Bias
The offspring of nuclear families were analyzed 
to determine whether mendelian distribution ra-
tios associated with autosomal dominant inheri-
tance were observed in children of carriers of the 
long-QT syndrome. For mendelian inheritance, 
the expected findings were that 50% of the off-
spring carried the mutated allele, that the sex 
ratio was balanced among the sibship who were 
carriers, and that the frequencies of maternal 
and paternal transmission of the mutation were 
similar. We corrected for single ascertainment12 
to prevent bias toward families with large num-
bers of carriers by excluding from transmission 
analysis all probands in the ascertained sibships.
Statistical Analysis
We used the chi-square test to evaluate the ob-
served distribution of offspring of parents carry-
ing a long-QT allele. All P values were two-sided 
unless otherwise stated, and a P value of less than 
0.05 was used to indicate statistical significance. 
The Bonferroni correction was applied to correct 
for multiple comparisons. Transmission analysis 
was conducted with the use of R statistical soft-
ware.13 The phenotypic data (including clinical 
symptoms and the presence or absence of a fam-
ily history of sudden death typical of the long-QT 
syndrome) were compared between probands and 
other family members carrying long-QT alleles, 
and the mean QTc intervals were calculated with 
the use of Stata SE 8.1 statistical software.
R esult s
Our study included 240 pedigrees of families of 
European origin carrying 59 mutations causing 
the long-QT syndrome type 1 and 83 mutations 
causing the long-QT syndrome type 2. By defini-
tion, probands had markedly prolonged QTc inter-
vals (mean [±SD], 493±44 msec for the long-QT 
syndrome type 1 and 505±53 msec for the long-QT 
syndrome type 2). The majority of probands had 
had syncope, aborted cardiac arrests, or both, 
whereas the symptoms were less prevalent and 
the QTc intervals were less prolonged among other 
family members who were carriers. Among fam-
ily members who were not probands, 388 carriers 
of the long-QT syndrome type 1 had a mean QTc 
interval of 465±32 msec, and only 32% were symp-
tomatic; 316 with the long-QT syndrome type 2 
had a mean QTc interval of 470±39 msec and only 
35% were symptomatic. Of the pedigrees studied, 
37% of those with the long-QT syndrome type 1 
and 47% of those with the long-QT syndrome 
type 2 involved a family history of sudden death 
typical of the long-QT syndrome. Among the pedi-
grees with type 1, 50 involved the same Finnish 
founder mutation (KCNQ1 G589D) localized in the 
cytoplasmic C-terminal domain. In comparison, 
Fodstad et al. reported a mean QTc of 462±38 msec 
among carriers of that mutation, 30% of whom 
were symptomatic.11 Of the Finnish pedigrees of 
the long-QT syndrome type 1 included in our study, 
20% involved a family history of sudden death.
In accordance with previous reports, we ob-
served a marked female predominance among the 
234 clinically diagnosed probands (159 [68%], 
vs. 75 male probands [32%]; P<0.001) (Table 1). 
Correction of ascertainment bias led to the exclu-
sion from transmission analysis of 157 probands 
within the sibships; more female than male pro-
bands were excluded (103 vs. 54).
Transmission analysis was first limited to one 
nuclear family per pedigree in order to maximize 
the correction for ascertainment bias, as well as to 
minimize the potential bias of mutations in large 
pedigrees that contributed multiple nuclear fam-
ilies to the study population. We observed marked 
female carrier predominance among the descen-
dants (for the long-QT syndrome type 1, 65 female 
vs. 46 male carriers; for the long-QT syndrome 
type 2, 69 female vs. 43 male carriers) (Table 1). 
The proportion of mutation carriers in nuclear 
families with type 1 or type 2 was higher than ex-
pected, indicating that transmission of mutations 
causing the long-QT syndrome was skewed. When 
both subpopulations were combined, we identi-
fied 134 female carriers and 89 male carriers of 
the long-QT syndrome and 84 female and 88 
male noncarriers (Bonferroni-corrected P<0.001) 
(Table 1).
Transmission analysis was then extended to 
all eligible nuclear families with the long-QT syn-
drome (753 families). Assessment of sex ratio and 
mutation segregation in the entire study popula-
tion after correction for ascertainment bias re-
vealed that similar numbers of females (52%) 
and males (48%) were born to parents with the 
long-QT syndrome (Table 1 and Fig. 1). As in the 
single nuclear families, distortion of mutation 
transmission was observed among all nuclear 
families with the long-QT syndrome. More off-
Copyright © 2006 Massachusetts Medical Society. All rights reserved. 
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spring than expected were born with mutations 
causing the long-QT syndrome type 1 (566 per-
sons [57%]) or with type 2 (304 persons [57%]). 
A persistent female predominance among muta-
tion carriers was observed in both subgroups. 
Among the 870 carriers, the allele for the long-QT 
syndrome was transmitted more often to female 
offspring (476 [55%]) than to male offspring (394 
[45%], P = 0.005).
Since most pedigrees involved unique muta-
tions causing the long-QT syndrome, we separately 
investigated persons with the Finnish founder mu-
tation that causes the long-QT syndrome type 1 
(KCNQ1 G589D). This subgroup represented 451 
(45%) of the descendants of parents with the 
long-QT syndrome type 1 in the study population 
and 191 of the 484 nuclear families. Transmission 
of the KCNQ1 G589D mutation was slightly in-
creased among the descendants in this subgroup, 
and 243 (54%) were carriers. A trend toward a 
higher number of female than male carriers of the 
mutation was also observed (131 women [54%]). 
In contrast, the 549 offspring who were hetero-
geneous for mutations causing the long-QT syn-
drome type 1 carried 58 different mutations, many 
of them affecting transmembrane domains. This 
subgroup featured higher proportions of muta-
tion carriers (323 [59%]) than noncarriers (226 
[41%]) and of female carriers (172 [61%]) than fe-
male noncarriers (108 [39%]). In summary, muta-
tion transmission was significantly distorted for 
all subgroups analyzed, with the exception of the 
Finnish subgroup that carried the KCNQ1 G589D 
founder mutation, which nevertheless showed a 
similar trend toward higher proportions of mu-
tation carriers and female carriers.
Table 1. Study Population and Transmission Analysis Corrected for Ascertainment Bias.
Category Total Female Proportion
Long-QT 
Syndrome
Long-QT 
Syndrome Type 1
Long-QT 
Syndrome Type 2
Long-QT 
Syndrome
Long-QT 
Syndrome Type 1
Long-QT 
Syndrome Type 2
number number (percent)
Study population
Pedigrees 240 143 97 — — —
Mutations 142 59 83 — — —
Probands 234* 137* 97 159 (68) 88 (64) 71 (73)
Excluded probands 157 93 64 103 (66) 59 (63) 44 (69)
Transmission analysis in one nuclear family per pedigree
Nuclear families 191 94† 97 — — —
Descendants 395 191 204 218 (55) 100 (52) 118 (58)
Mutation carriers 223 (56)‡ 111 (58)‡ 112 (55)‡ 134 (60) 65 (59) 69 (62)
Noncarriers 172 80 92 84 (49) 35 (44) 49 (53)
P value§ <0.001 0.02 0.03
Transmission analysis in all nuclear families
Nuclear families 753 484 269 — — —
Descendants 1534 1000 534 803 (52) 514 (51) 289 (54)
Mutation carriers 870 (57)‡ 566 (57)‡ 304 (57)‡ 476 (55) 303 (54) 173 (57)
Noncarriers 664 434 230 327 (49) 211 (49) 116 (50)
P value§ <0.001 <0.001 <0.001 — — —
* In six pedigrees, five from Finland, the proband belonged to a family branch not investigated by a genetic referral center participating in this 
study.
† These 94 families included 93 with various mutations causing the long-QT syndrome type 1 and 1 with the founder mutation KCNQ1 
G589D.
‡ The percentage is based on the total number of descendants for the syndrome or subtype.
§ The P value was obtained from the chi-square test (with 3 degrees of freedom) of the distribution of mutations as compared with that pre-
dicted by mendelian inheritance (four equivalent groups: female carriers, female noncarriers, male carriers, and male noncarriers). The 
Bonferroni-corrected significance level for six comparisons was P<0.008.
Copyright © 2006 Massachusetts Medical Society. All rights reserved. 
Downloaded from www.nejm.org at HAUPTBIBLIOTHEK UNIVERSITAET on April 27, 2009 . 
T h e  n e w  e ng l a nd  j o u r na l  o f  m e dic i n e
n engl j med 355;26 www.nejm.org december 28, 20062748
Although equal numbers of maternal and pa-
ternal transmission events are expected in mende-
lian transmission, we observed a higher number 
of maternal transmissions of mutations causing 
the long-QT syndrome. Indeed, among 837 off-
spring, the deleterious allele was inherited ma-
ternally in 516 children (62%) and paternally in 
321 children (38%). The high number of mothers 
who were carriers, however, might have led to the 
observed increased maternal transmission. The 
parental origin of the mutation for the long-QT 
syndrome was known for 174 of 234 probands 
(Table 2). In this subgroup, we observed that mu-
tations were inherited more often from the moth-
er (106 probands [61%]) than from the father (68 
probands [39%]). Increased maternal transmission 
was observed among probands with the long-QT 
syndrome type 1 or type 2.
Transmission analysis involving the entire study 
population was conducted, stratified according 
to the parental origin of the mutation (Table 3). 
This analysis revealed that the skewed transmis-
sion in nuclear families with the long-QT syn-
drome type 1 was due to the markedly increased 
female transmission of the mutated allele to off-
spring (P<0.001), whereas male carriers in this 
subgroup showed a balanced, mendelian trans-
mission (P = 0.57). Transmission analysis in nu-
clear families with the long-QT syndrome type 2 
showed a different pattern of parental transmis-
sion, however. Fathers with the long-QT syndrome 
type 2 had a markedly skewed mutation transmis-
sion (P = 0.009). Among their offspring, transmis-
sion of the mutated allele was favored (117 carri-
ers [62%]), and there was a slight excess of female 
carriers (62 carriers [53%]) over male carriers (55 
[47%]). Mothers with the long-QT syndrome 
type 2 had nonsignificant transmission distortion 
(P = 0.13). They transmitted the mutated allele to 
53% of their offspring, and transmission to daugh-
ters was favored: the proportion of female carri-
ers (100 [58%]) was higher than the proportion 
of male carriers (73 [42%]). In summary, the trans-
mission analysis according to parental origin of 
the mutation provided evidence of a trend of fe-
male carriers transmitting the deleterious alleles 
more often to their daughters than to their sons.
Discussion
We analyzed mutation segregation, sex ratio, and 
parental transmission in a population composed 
of mutation carriers and all their offspring, in 
which the long-QT syndrome was genetically and 
clinically ascertained. Classic mendelian-inheri-
tance ratios expected for an autosomal dominant 
trait were not observed among the offspring of 
female carriers of the long-QT syndrome type 1 
allele or among mothers and fathers carrying an 
allele for the long-QT syndrome type 2.
We investigated the nuclear families of pro-
band-ascertained pedigrees of the long-QT syn-
drome for which all offspring were genotyped 
and applied correction for single ascertainment. 
By these means, we corrected for selection bias due 
to incomplete or sex-specific penetrance of the 
mutations for the long-QT syndrome, such as the 
underdiagnosis of asymptomatic male carriers or 
The Long-QT Syndrome Type 1 The Long-QT Syndrome Type 2
P<0.001
P<0.001
P<0.001
P=0.02
P=0.001 230304434566
303
(30%)
211
(21%)
263
(26%)
223
(22%)
173
(32%)
116
(22%)
131
(25%)
114
(21%)
484 269
Figure 1. Transmission Analysis.
Female predominance and segregation distortion among offspring (cor-
rected for ascertainment bias) of parents with the long-QT syndrome are 
shown. Shaded diamonds represent parental carriers of the long-QT syn-
drome, shaded circles female and shaded squares male offspring who are 
carriers, white circles female and white squares male offspring who are non-
carriers, and white rectangles total numbers of offspring who are carriers 
or noncarriers. Percentages are calculated as the number divided by the 
 total number. Percentages do not total 100 because of rounding.
Table 2. Parental Transmission of the Long-QT Syndrome to Probands.
Syndrome Probands Transmission to Proband
Maternal Paternal Unknown
number
Long-QT syndrome 234 106 68 60
Type 1 137 64 43 30
Type 2 97 42 25 30
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the higher likelihood of cardiac events, diagno-
sis of the long-QT syndrome, or both among 
women, owing to their longer QTc intervals. The 
applied correction for ascertainment bias resulted 
in the exclusion of nearly twice as many female 
as male probands.
Of all probands, 68% were female. This obser-
vation was in accordance with earlier evidence of 
the marked female predominance in symptom-
atic long-QT syndrome.2-4,6,14,15 The reasons for 
the increased risk among women of cardiac symp-
toms and of diagnosis of the long-QT syndrome 
on electrocardiography have been discussed at 
length. First, it is well established that the QTc 
interval is longer in women than in men.9 Thus, 
abnormal QT prolongation is more likely to be 
detected on electrocardiography in women. The 
biologic basis for this sex difference might be the 
down-regulation of expression of cardiac potassi-
um-channel genes by female sex hormones, which 
has been shown to prolong the QT interval.16 Fur-
thermore, women may be at higher risk for symp-
tomatic arrhythmias and sudden death than men 
and, if cardiac events occur, may have a higher 
mortality rate, even after adjustment for age.17 
Longer QTc intervals may predispose women to 
ventricular arrhythmias, torsade de pointes in 
particular. In addition to predisposing physio-
logical factors, women have been shown to be 
more prone to torsade de pointes during expo-
sure to QT-prolonging drugs.18 Finally, β-adrener-
gic blockade has been reported to be less effi-
cient in women with the long-QT syndrome than 
in men with the syndrome.19 Taken together, all 
these factors may contribute to the described fe-
male predominance among phenotypically affect-
ed populations.3-5,7,8,14,15,20,21
The main finding of our study was that meiotic 
drive, which results in some alleles being over-
represented, favors the transmission of mutant 
alleles to daughters even in subpopulations cor-
rected for the method of proband selection. There-
fore, increased penetrance of the mutation for the 
long-QT syndrome in women is not the only fac-
tor resulting in female predominance. The ob-
served transmission distortion could be due to 
positive selection of the mutated allele during ga-
metogenesis or during postfertilization processes. 
A selection bias that eliminates male carriers of 
the long-QT syndrome before birth could also re-
sult in an excess of genetically affected females. 
However, among persons with the long-QT syn-
drome, the greater number of mutation carriers 
(female and male) than noncarriers does not pro-
vide support for a negative-selection hypothesis.
Transmission distortion has previously been 
reported in invertebrates as well as in mammals. 
Specific genetic loci and molecular mechanisms 
involved in transmission distortion have been in-
vestigated in drosophila22 and mice.23 Genome-
wide transmission distortion involving numerous 
genetic loci was recently reported in a consan-
guineous human subpopulation.24 The skewed 
segregation of disease-causing alleles has been 
Table 3. Transmission Analysis According to Parental Origin of the Mutation.
Subgroup
Total No. 
of Patients 
(N = 1489)* Carriers
Female 
Carriers Daughters Sons P Value†
 Carriers Noncarriers Carriers Noncarriers
no. of offspring (%) no.
Long-QT syndrome type 1
Maternal 587 343 (58) 190 (55) 190 120 153 124 <0.001
Paternal 385 204 (53) 102 (50) 102 85 102 96 0.57
Long-QT syndrome type 2
Maternal 328 173 (53) 100 (58) 100 80 73 75 0.13
Paternal 189 117 (62) 62 (53) 62 33 55 39 0.009
* The parental-transmission status was unknown for 45 descendants.
† The P value was obtained from the chi-square test (with 3 degrees of freedom) of the distribution of mutations as compared with that pre-
dicted by mendelian inheritance (four equivalent groups: female carriers, female noncarriers, male carriers, and male noncarriers). The 
Bonferroni-corrected significance level for four comparisons was P<0.013.
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described in human genetic disease mediated by 
expanded trinucleotide repeats25 and in recessive 
congenital disorders.26
Our results revealed that the paternal muta-
tion for the long-QT syndrome type 1 is neutral 
and has no positive selection effect at the popu-
lation level, since transmission and sex ratios were 
found to be in accord with mendelian inheritance. 
A possible explanation for this finding is that the 
locus for the long-QT syndrome type 1, 11p15.5, 
is paternally imprinted during early ontogenesis. 
The exclusive maternal expression of KCNQ1 has 
been reported for various fetal tissues.27,28 Al-
though true gametic imprinting is thought to be 
conserved throughout development,29 the pater-
nal allele for the long-QT syndrome type 1 is ex-
pressed in mature cardiac muscle, as evidenced 
by the occurrence of paternally inherited long-QT 
syndrome type 1. We suggest that repression of 
the paternally inherited mutations for the long-
QT syndrome type 1 due to the gametic imprint 
leads to the observed normal mendelian trans-
mission.
Mechanisms resulting in the positive selec-
tion of mutations for the long-QT syndrome are 
unknown. The mutation might confer a reproduc-
tive advantage during the maturation, fertiliza-
tion, implantation, and postimplantation devel-
opment of the gamete by leading to variation in 
potassium flow and alteration of membrane po-
tential. Yet the positive selection of the mutated 
allele seems to be independent of the detrimen-
tal cardiac effect later in life.
Though the observed transmission distortion 
may be directly linked to the deleterious effect of 
the mutation for the long-QT syndrome on potas-
sium-channel function, we cannot rule out with 
certainty that no hidden bias remains in our Eu-
ropean study population, since the retrospective 
study design is inherently vulnerable to involun-
tary bias in population selection. Therefore, to 
shed light on these issues, future studies should 
be prospective and should involve systematic trans-
mission analysis of the mutation for the long-QT 
syndrome in nuclear families ascertained through 
nonindex patients.
In conclusion, we report transmission distor-
tion among persons with the long-QT syndrome, 
owing to positive selection of the mutated allele 
in a large population corrected for ascertainment 
bias and including a large proportion of asymp-
tomatic persons. We found compelling evidence 
of the unbalanced transmission of the deleteri-
ous alleles causing the long-QT syndrome types 1 
and 2. Our results show that the probability of 
inheriting a mutation for the long-QT syndrome 
is higher than expected according to mendelian 
inheritance and that in maternal transmission, 
daughters are favored. Therefore, the skewed seg-
regation of the mutation from mothers to their 
daughters might contribute substantially to the 
observed female predominance in the long-QT 
syndrome.
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